Usana Health Sciences Inc (USNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 45,651 | 33,556 | 29,945 | 45,030 | 40,365 |
| Depreciation Amortization | 7,916 | 7,069 | 6,697 | 5,333 | 5,562 |
| Income taxes - deferred | 3,194 | -2,296 | -2,435 | -1,565 | -1,304 |
| Accounts payable and accrued liabilities | -1,981 | -1,138 | 686 | -3,140 | 4,374 |
| Other Working Capital | 1,296 | -14,625 | 5,501 | 3,422 | 13,625 |
| Other Operating Activity | 10,032 | 9,903 | 5,562 | 9,125 | -1,332 |
| Operating Cash Flow | $66,108 | $32,469 | $45,956 | $58,205 | $61,290 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,159 | -3,291 | -15,913 | -25,467 | -11,020 |
| Net Acquisitions | -42,694 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | 94 | 707 | -543 | -660 |
| Investing Cash Flow | $-46,853 | $-3,197 | $-15,206 | $-26,010 | $-11,680 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 31,150 | 57,020 | 85,020 | 104,093 | N/A |
| Common Stock Issued | 12,005 | 131 | 746 | 3,148 | 3,547 |
| Common Stock Repurchased | -17,031 | -1,654 | -39,873 | -79,580 | -40,958 |
| Other Financing Activity | -35,701 | -84,999 | -75,658 | -74,547 | 4,193 |
| Financing Cash Flow | $-9,577 | $-29,502 | $-29,765 | $-46,886 | $-33,218 |
| Exchange Rate Effect | 886 | 607 | -569 | 527 | 58 |
| Beginning Cash Position | 13,658 | 13,281 | 12,865 | 27,029 | 10,579 |
| End Cash Position | 24,222 | 13,658 | 13,281 | 12,865 | 27,029 |
| Net Cash Flow | $10,564 | $377 | $416 | $-14,164 | $16,450 |
| Free Cash Flow | |||||
| Operating Cash Flow | 66,108 | 32,469 | 45,956 | 58,205 | 61,290 |
| Capital Expenditure | -4,192 | -4,128 | -16,061 | -26,264 | -11,038 |
| Free Cash Flow | 61,916 | 28,341 | 29,895 | 31,941 | 50,252 |